Table 2.

Treatment courses used in the treatment of patients with hepatitis C virus infection who finished the treatment course before the lockdown

Comorbidities	Course				Total	RVR	SVR
	SOF/RIB	SOF, RIB and PIFN	SOF/LED	SOF/DAC
No comorbidities	0	13	68	0	79	58 (73.4%)	81 (100%)
Thalassaemia	0	3	2	0	5	4 (80%)	5 (100%)
ESRD	0	0	0	2	2	2 (100%)	2 (100%)
Renal transplant	2	0	2	0	4	0 (0%)	4 (100%)

DAC=daclatasvir, ESRD=end-stage renal disease, LED=ledipasvir, PIFN=peg-interferon, RIB=ribavirin, SOF=sofosbuvir, SVR=sustained virologic response, RVR=rapid viral response